News
BLCM
0.080
-3.49%
-0.003
Weekly Report: what happened at BLCM last week (0219-0223)?
Weekly Report · 2d ago
Bellicum Pharmaceuticals Appoints New CEO During Dissolution
TipRanks · 4d ago
Bellicum sells assets to MD Anderson, moves towards liquidation
Healthcare Bellicum sells assets to MD Anderson, moves towards liquidation. Bellicum Pharmaceuticals said it has completed the sale of substantially all of its assets to the University of Texas MD Anderson Cancer Center. The company's shareholders have voted to proceed with the liquidation and dissolution of the company.
Seeking Alpha · 5d ago
Bellicum Pharmaceuticals Finalizes Sale and Approves Dissolution
TipRanks · 6d ago
Weekly Report: what happened at BLCM last week (0212-0216)?
Weekly Report · 02/19 11:51
Weekly Report: what happened at BLCM last week (0205-0209)?
Weekly Report · 02/12 11:38
Weekly Report: what happened at BLCM last week (0129-0202)?
Weekly Report · 02/05 11:49
Bellicum Pharmaceuticals Asset Sale and Dissolution Vote Adjourned
TipRanks · 01/31 09:35
Weekly Report: what happened at BLCM last week (0122-0126)?
Weekly Report · 01/29 11:35
Bellicum Pharmaceuticals Asset Sale and Dissolution Vote Adjourned
TipRanks · 01/25 09:22
Bellicum Pharmaceuticals Security Holders Voting Overview
TipRanks · 01/25 09:22
Bellicum Pharmaceuticals Introduces Super-Voting Shares and Changes Quorum Requirement
TipRanks · 01/25 09:22
Bellicum Pharmaceuticals Issues Super-Voting Share Privately
TipRanks · 01/25 09:21
Weekly Report: what happened at BLCM last week (0115-0119)?
Weekly Report · 01/22 11:40
Weekly Report: what happened at BLCM last week (0108-0112)?
Weekly Report · 01/15 11:36
Weekly Report: what happened at BLCM last week (0101-0105)?
Weekly Report · 01/08 11:40
Weekly Report: what happened at BLCM last week (1225-1229)?
Weekly Report · 01/01 11:34
Weekly Report: what happened at BLCM last week (1218-1222)?
Weekly Report · 12/25/2023 11:48
Weekly Report: what happened at BLCM last week (1211-1215)?
Weekly Report · 12/18/2023 11:55
Weekly Report: what happened at BLCM last week (1204-1208)?
Weekly Report · 12/11/2023 11:48
More
Webull provides a variety of real-time BLCM stock news. You can receive the latest news about Bellicum Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About BLCM
Bellicum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing novel, controllable cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors. Its Chemical Induction of Dimerization (CID), technology platform is designed to enable control of components of the immune system in real time. CID consists of molecular switches, modified forms of these signaling proteins, which are triggered inside the patient by infusion of a small molecule, instead of by natural upstream signals. It has developed two such switches: an activation switch, designed to stimulate activation, proliferation and persistence of the immunotherapy cells and provide other immunomodulatory benefits, and a safety switch, designed to initiate programmed cell death, or apoptosis, of the immunotherapy cell.